Castle Biosciences, Inc. (CSTL)

Castle Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 5, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	877	581	620	1,103	1,622	587
Market Cap Growth	74.70%	-6.38%	-43.76%	-32.00%	176.41%	-
Enterprise Value	680	366	368	740	1,461	517
Last Close Price	33.64	21.58	23.54	42.87	67.15	34.37
PE Ratio	152.21	-10.06	-9.14	-34.44	-123.60	-165.14
PS Ratio	2.97	2.64	4.53	11.72	25.89	11.31
PB Ratio	2.13	1.48	1.55	2.68	3.90	6.89
P/FCF Ratio	27.02	-30.17	-13.12	-49.10	317.18	96.55
P/OCF Ratio	15.79	-103.22	-14.89	-58.11	164.43	83.65
EV/Sales Ratio	2.18	1.66	2.68	7.86	23.33	9.97
EV/EBITDA Ratio	54.77	-6.57	-4.56	-20.18	-183.79	67.30
EV/EBIT Ratio	-536.18	-5.38	-4.04	-18.46	-173.49	70.59
EV/FCF Ratio	19.69	-18.99	-7.78	-32.93	285.78	85.10
Debt / Equity Ratio	0.06	0.04	0.03	0.02	-	0.30
Debt / EBITDA Ratio	1.74	-	-	-	-	3.27
Debt / FCF Ratio	0.77	-0.80	-0.29	-0.37	-	4.13
Asset Turnover	0.66	0.49	0.30	0.21	0.22	0.73
Inventory Turnover	9.15	7.55	10.67	7.47	5.61	6.90
Quick Ratio	7.45	5.90	7.81	13.94	20.24	7.42
Current Ratio	7.78	6.20	8.09	14.21	20.58	7.63
Return on Equity (ROE)	1.47%	-14.54%	-16.56%	-7.56%	-4.11%	14.06%
Return on Assets (ROA)	-0.14%	-9.43%	-12.52%	-5.55%	-1.88%	6.44%
Return on Capital (ROIC)	-0.15%	-10.37%	-13.68%	-5.99%	-2.00%	7.35%
Earnings Yield	0.65%	-9.90%	-10.82%	-2.84%	-0.63%	0.90%
FCF Yield	3.70%	-3.31%	-7.62%	-2.04%	0.32%	1.04%
Buyback Yield / Dilution	-6.54%	-2.87%	-3.65%	-32.80%	-118.63%	-354.25%
Total Shareholder Return	-6.54%	-2.87%	-3.65%	-32.80%	-118.63%	-354.25%

Source: S&P Capital IQ. Standard template. Financial Sources.